Bimekizumab: the first bispecific biologic agent facing phase III trial program in both plaque psoriasis and psoriatic arthritis. Issue 3 (2019)

Record Type:: Journal Article
Title:: Bimekizumab: the first bispecific biologic agent facing phase III trial program in both plaque psoriasis and psoriatic arthritis. Issue 3 (2019)
Main Title:: Bimekizumab: the first bispecific biologic agent facing phase III trial program in both plaque psoriasis and psoriatic arthritis
Authors:: Chiricozzi, A
Romanelli, M
Is Part Of:: Journal of translational science. Volume 5:Issue 3(2019)
Journal:: Journal of translational science
Issue:: Volume 5:Issue 3(2019)
Issue Display:: Volume 5, Issue 3 (2019)
Year:: 2019
Volume:: 5
Issue:: 3
Issue Sort Value:: 2019-0005-0003-0000
Page Start:
Page End:
Publication Date:: 2019
Subjects:: Clinical medicine -- Research -- Periodicals
Medicine, Experimental -- Periodicals
Human experimentation in medicine -- Periodicals
616.027
Journal URLs:: http://www.oatext.com/Journal-of-Translational-Science-JTS.php ↗
DOI:: 10.15761/JTS.1000272 ↗
Languages:: English
ISSNs:: 2059-268X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library HMNTS - ELD Digital store
Ingest File:: 18502.xml